Vaccines

Increasingly public health policies in Europe recognise the importance and value of vaccination. However, to ensure continued stability and provide a supportive environment for ongoing investment in innovative new vaccines, long-term partnership and collaboration between policy makers, public health authorities and industry is crucial.

Vaccine innovations developed over recent years offer individuals and communities the possibility of protection against an increasing number of diseases. Consequently, the Health Service Executive needs to continue to drive vaccination forward, as immunisation represents one of the most cost-effective health interventions available.

 

 

Related Content

Test tubes
The Value of Vaccines  

IPHA is a member of -

IFPMAAESGPEFPIA

For medicines and clinical trials information visit -

medicines.ieself-care.ieIFPMA Portal